Reverse Payments, Mergers Take Center Stage In Q1

Law360, New York (April 19, 2010, 2:24 PM EDT) -- The first three months of 2010 saw judges weigh in on a number of significant issues in competition law, largely rejecting plaintiffs' challenges to reverse payment deals in the drug industry and allowing the U.S. government to go ahead with challenges to consummated mergers.

Here are five of the most important decisions of the quarter:

AndroGel Antitrust Litigation

Going after so-called reverse payment settlements in the pharmaceutical industry has been a continuing battle for the Federal Trade Commission and private plaintiffs alike, and the first quarter...
To view the full article, register now.